NewsBenzingaNovo Nordisk Q3 Adj. EPS $0.87 Beats $0.81 Estimate, Sales $11.900B Beat $11.390B Estimate Novo Nordisk Q3 Adj. EPS $0.87 Beats $0.81 Estimate, Sales $11.900B Beat $11.390B Estimate Benzinga 2026.11.04 06:55 (GMT+0) Open on Benzinga Other news Stock Market Today: Dow Jones, S&P 500 Futures Rise as Democrats Take Control of Congress—AMD, AMGN, NVO in Focus Needham Maintains Buy on Duolingo, Raises Price Target to $165 Needham Maintains Buy on RxSight, Lowers Price Target to $7 Why AMD May Weather the PC Storm Better Than Intel BTIG Reiterates Buy on Booking Holdings, Maintains $250 Price Target Top Wall Street Forecasters Revamp McDonald's Expectations Ahead Of Q3 Earnings
Stock Market Today: Dow Jones, S&P 500 Futures Rise as Democrats Take Control of Congress—AMD, AMGN, NVO in Focus
